52.80
+2.72%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Clinica Baviera
Its shares trade on BME under the ticker CBAV.MC. It has been listed since 1 January 2000. In the fiscal year to 31 December 2025, it reported revenue of €301.8m and net income of €42.1m. At that date it held total assets of €247.5m and shareholders' equity of €110.0m.
Clínica Baviera SA is engaged in the provision of diagnosis and treatment for eye disorders. The company is headquartered in Madrid, Madrid. The company went IPO on 2000-01-01. The firm focuses on providing services within the field of ophthalmic medicine. The firm is specialized in the diagnosis and treatment of eye disorders, including myopia, hyperopia, astigmatism, cataracts, glaucoma, vitreous-retina and strabismus, among others. The firm operates a network of clinics located in various European countries, such as Spain, Germany, Austria and Italy. In addition, the Company is a parent of the Baviera Group, a group that comprises a number of controlled entities, including Clinica Baviera Italia Srl, Clinica Baviera Mallorca SL, Care Vision Germany GmbH and Castellana de Intermediacion Sanitaria SL, among others. The main shareholder of the Company is Aier Eye International (Europe) Slu.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 1 Jan 2000
- Employees
- 1,161
- Website
- clinicabaviera.com ↗
Leadership
Pay as last reported
- Mr. Bang ChenChairman of the Board, Proprietary Director
- Mr. Eduardo Baviera SabaterExecutive Vice Chairman of the Board, Chief Executive Officer, since 1994€394,000
- Mr. Virgilio Leal EspiChief Financial Officer
- Ms. Marisa Tuset SabaterChief Operating Officer, Spain
- Mr. Fernando Jose Carrero BoschChief Human Resources Officer
- Mr. Juan Garcia MorinigoChief Internal Audit Officer
- Mr. Luis Gravalos SoriaCountry Manager, Germany and United Kingdom
- Mr. Antonio Munoz Sanchez De MolChief Digital Transformation Officer
- Ms. Belen Olaguibel Lopez BoschCorporate Director
- Mr. Antonio Peral Ortiz De La ToNon-Member Secretary of the Board
- Mr. Li LiProprietary Director
- Mr. Shijun WuProprietary Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 74
- Environment
- 77
- Social
- 94
- Governance
- 50
- Direct emissions (scope 1)
- 72.5 t
- Energy emissions (scope 2)
- 73.5 t
- Women in the workforce
- 80.17956%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Clinica Baviera SA has a strong brand reputation and a well-established presence in the market for providing high-quality eye care services.
- The company boasts a team of experienced and skilled healthcare professionals who are dedicated to delivering excellent patient care.
- Clinica Baviera SA operates a network of advanced clinics equipped with state-of-the-art technologies, allowing them to offer a wide range of innovative eye treatments and surgeries.
Weaknesses
- Clinica Baviera SA may face challenges in terms of high operational costs due to the need for expensive medical equipment and continuous staff training.
- The company heavily relies on the local market and may be vulnerable to economic downturns or changes in healthcare regulations.
- Clinica Baviera SA may struggle with limited brand recognition and market penetration in some regions, which could affect their growth potential.
Opportunities
- The rising demand for corrective eye surgeries and treatments presents a significant growth opportunity for Clinica Baviera SA.
- Expansion into new international markets where the demand for specialized eye care services is increasing could lead to additional revenue streams.
- Technological advancements in the field of eye care create opportunities for Clinica Baviera SA to offer innovative solutions and attract a wider customer base.
Threats
- Intense competition from local and international eye care providers poses a threat to Clinica Baviera SA's market share.
- Changes in healthcare policies and regulations may impact the reimbursement rates or eligibility criteria for certain medical procedures, potentially affecting the company's profitability.
- Negative publicity, such as patient dissatisfaction or medical malpractice claims, could harm the company's reputation and erode consumer trust.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.